Data Report
Covid19 => Covid Treatments => Topic started by: Data Report on May 15, 2023, 04:44:35 pm
-
On the one hand, an unfortunate development but, on the other hand, completely understandable given the circumstances.
Pfizer & Moderna dominated the initial market in the US and, subsequently, never relinquished it. J&J had an initial advantage being only one shot and also capable of not needing special cold storage. However, factors such as limited vaccine acceptance & it's initial problems with manufacturing ultimately doomed it.
-
J&J Covid-19 vaccine, no longer available in the US
Source of information
1. CNN
https://www.cnn.com/2023/05/15/health/johnson-johnson-covid-vaccine-end/index.html